Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Influence of radioactive contaminants on absorbed dose estimates for radiopharmaceuticals

Conference ·
OSTI ID:5219719
Several popular radiopharmaceutical products contain low levels of radioactive contaminants. These contaminants increase the radiation absorbed dose to the patient without any increased benefit and, in some cases, with a decrease in image quality. The importance of a contaminant to the radiation dosimetry picture is a function of (1) the contaminant level, (2) the physical half-life of the contaminant, (3) the organ uptake and the biological half-time of the contaminant in the various body systems, and (4) the decay mode, energy, etc. of the contaminant. The general influence of these parameters is discussed in this paper; families of curves are included that reflect the changing importance of contaminant dosimetry with respect to the primary radionuclide as a function of these variables. Several specific examples are also given of currently used radiopharmaceutical products which can contain radioactive contaminants (I-123, In-111, Tl-201, Ir-191m, Rb-82, Au-195m). 7 refs., 8 figs., 4 tabs.
Research Organization:
Oak Ridge Associated Universities, Inc., TN (USA)
DOE Contract Number:
AC05-76OR00033
OSTI ID:
5219719
Report Number(s):
CONF-851113-7; ON: DE87000309
Country of Publication:
United States
Language:
English